A similar but delayed pattern was observed for TCF1, a transcription factor associated with “stem-like” properties and responsiveness to PD-1 blockade therapy among CD8+ tumor-infiltrating lymphocytes (Sade-Feldman et al., 2018; Siddiqui et al., 2019). This evidence concerns the gene CD8A and neoplasm.